XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2019   0 13,178,000     (38,000)
Beginning balance at Dec. 31, 2019 $ 247,693 $ 0 $ 132 $ 110,573 $ 137,478 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 17     17    
Issuance of restricted stock (in shares)     95,000      
Compensation expense on restricted common stock 486   $ 1 485    
Taxes paid related to net shares settlement of equity awards (149)     (149)    
Net income (loss) 4,082       4,082  
Ending balance (in shares) at Mar. 31, 2020   0 13,273,000     (38,000)
Ending balance at Mar. 31, 2020 252,129 $ 0 $ 133 110,926 141,560 $ (490)
Beginning balance (in shares) at Dec. 31, 2019   0 13,178,000     (38,000)
Beginning balance at Dec. 31, 2019 247,693 $ 0 $ 132 110,573 137,478 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 3,685          
Ending balance (in shares) at Sep. 30, 2020   0 13,290,000     (38,000)
Ending balance at Sep. 30, 2020 252,858 $ 0 $ 133 112,052 141,163 $ (490)
Beginning balance (in shares) at Mar. 31, 2020   0 13,273,000     (38,000)
Beginning balance at Mar. 31, 2020 252,129 $ 0 $ 133 110,926 141,560 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 1     1    
Issuance of restricted stock (in shares)     13,000      
Compensation expense on restricted common stock 562     562    
Net income (loss) 165       165  
Ending balance (in shares) at Jun. 30, 2020   0 13,286,000     (38,000)
Ending balance at Jun. 30, 2020 252,857 $ 0 $ 133 111,489 141,725 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on common stock options 1     1    
Issuance of restricted stock (in shares)     4,000      
Compensation expense on restricted common stock 562     562    
Net income (loss) (562)       (562)  
Ending balance (in shares) at Sep. 30, 2020   0 13,290,000     (38,000)
Ending balance at Sep. 30, 2020 252,858 $ 0 $ 133 112,052 141,163 $ (490)
Beginning balance (in shares) at Dec. 31, 2020   0 13,296,000     (38,000)
Beginning balance at Dec. 31, 2020 251,544 $ 0 $ 133 112,615 139,286 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)     62,000      
Compensation expense on restricted common stock 474   $ 1 473    
Taxes paid related to net shares settlement of equity awards (224)     (224)    
Net income (loss) (394)       (394)  
Ending balance (in shares) at Mar. 31, 2021   0 13,358,000     (38,000)
Ending balance at Mar. 31, 2021 251,400 $ 0 $ 134 112,864 138,892 $ (490)
Beginning balance (in shares) at Dec. 31, 2020   0 13,296,000     (38,000)
Beginning balance at Dec. 31, 2020 $ 251,544 $ 0 $ 133 112,615 139,286 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Purchase of treasury shares (in shares) 432,731          
Purchase of treasury shares $ (4,400)          
Net income (loss) (3,569)          
Ending balance (in shares) at Sep. 30, 2021   0 13,394,000     (471,000)
Ending balance at Sep. 30, 2021 244,525 $ 0 $ 134 113,596 135,717 $ (4,922)
Beginning balance (in shares) at Mar. 31, 2021   0 13,358,000     (38,000)
Beginning balance at Mar. 31, 2021 251,400 $ 0 $ 134 112,864 138,892 $ (490)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of restricted stock (in shares)     36,000      
Compensation expense on restricted common stock 421     421    
Taxes paid related to net shares settlement of equity awards (110)     (110)    
Purchase of treasury shares (in shares)           175,000
Purchase of treasury shares (1,892)         $ (1,892)
Net income (loss) (1,918)       (1,918)  
Ending balance (in shares) at Jun. 30, 2021   0 13,394,000     (213,000)
Ending balance at Jun. 30, 2021 247,901 $ 0 $ 134 113,175 136,974 $ (2,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Compensation expense on restricted common stock 421     421    
Purchase of treasury shares (in shares)           258,000
Purchase of treasury shares (2,540)         $ (2,540)
Net income (loss) (1,257)       (1,257)  
Ending balance (in shares) at Sep. 30, 2021   0 13,394,000     (471,000)
Ending balance at Sep. 30, 2021 $ 244,525 $ 0 $ 134 $ 113,596 $ 135,717 $ (4,922)